Esch-sur-Alzette, July 1st 2022.
ITTM joined the IMI EU-PEARL project. EU-PEARL brings together patients, clinicians, industry, researchers and authorities to create an open and trusted environment for knowledge sharing and science-driven debate on innovative clinical trials. Extensive cooperation amongst all stakeholders to improve health outcomes for patients is the driving force behind EU-PEARL.
“EU-PEARL has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 853966-2. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA”.